| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107275 Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide, |
| 08/08/2002 | US20020107249 Administering a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine of at least about 5000, such as reboxetine; treating and prophylaxis of various psychological and neurological disorders |
| 08/08/2002 | US20020107221 Nucleosides with anti-hepatitis B virus activity |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |
| 08/08/2002 | US20020107197 Ligands for G protein coupled receptors and methods of using them |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020106777 Human PEC-60-like protein and DNA encoding this protein |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106630 Method of identifying HIBEF51 receptor inhibitors |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106366 Composition and method for reducing gastro-intestinal distress due to alpha-D-galactoside-linked/containing sugars |
| 08/08/2002 | DE10104880A1 Multipartikuläre Arzneiform, enthaltend mindestens zwei unterschiedlich überzogene Pelletformen A multiparticulate pharmaceutical form comprising at least two differently coated pellet forms |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436427A1 Compositions and method of tissue superoxygenation |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2436133A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | CA2436000A1 An antistress agent |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434808A1 Novel mixtures of microbial enzymes |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2434281A1 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2429969A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | CA2429359A1 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1228769A1 Symbiotic regenerative composition |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228758A1 Preventive or therapeutic agents for inflammatory diseases of intestine |
| 08/07/2002 | EP1228707A1 Use of alpha-lactalbumin as prebiotic agent |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228080A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228068A1 Polymorphic form of a tachykinin receptor antagonist |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228066A2 Sulfonamide derivatives |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228053A1 Substituted piperazine derivatives, the production and use thereof as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 08/07/2002 | EP1228052A1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1227835A1 Protease inhibitors as modulators of periodontal wound healing |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227821A1 Therapeutic compositions and methods of use thereof |
| 08/07/2002 | EP1227820A2 Oligosaccharide aldonic acids and their topical use |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227806A1 Pharmaceutical formulation containing tolterodine and its use |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP1227803A2 Methods and compounds for inhibiting amyloid deposits |
| 08/07/2002 | EP0914081B1 Storage stable dentifrice composition containing casein glycomacropeptide |
| 08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | EP0831856B1 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 08/07/2002 | EP0825869B1 Pharmaceutical composition comprising lactobacillus plantarum and arginine |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | EP0748217B1 Compositions comprising a mast cell degranulation-blocking h-1 receptor antagonist for the treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362949A 1,5-benzodiazepine derivatives as cck-A receptor agonists |
| 08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362875A Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues |
| 08/07/2002 | CN1362860A Low-molecular weight polymannuronate |
| 08/07/2002 | CN1362260A Medicine for treating anal disease and its prepn. |